國際參考定價是國際上許多國家進行藥品價格治理和醫(yī)保支付管理的重要工具之一。歐盟國家、日本、美國采用了藥品國際參考定價方法。我國進行藥品價格治理、新藥上市價格承諾和首發(fā)報價參考國際價格。建議藥品國際參考定價在創(chuàng)新藥先行試點，并逐步向醫(yī)保報銷藥品推開，出臺實施細則、審核監(jiān)督機制，完善價格治理綜合體系。

International reference pricing is one of the most important tools in drug price management and payment management. European Union countries, Japan, and the United States have adopted the international reference pricing for drugs. China is implementing drug price management, committing to new drug launch prices, and referencing external prices for initial pricing. It is suggested that international reference pricing for drugs be piloted in innovative drugs and gradually extended to drugs reimbursed by medical insurance. Implementation rules, audit and supervision mechanisms should be introduced to improve the comprehensive system of price governance.

R954